These results overall mechanistically demonstrate that iOPN represent a brake in TLR9-MYD88 signaling pathways in autoimmunity-driven B cell lymphomas, likely explaining why in OPN-deficient Faslpr/lpr mice the transformation of B cells occurs more frequently than in OPN-competent counterparts. Here, TLR9 is linked to B-cell non-Hodgkin lymphoma.